Quarterly report pursuant to Section 13 or 15(d)

Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding

v3.22.2.2
Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding
9 Months Ended
Sep. 30, 2022
$ / shares
shares
Schedule Of Common Stock Issuable Upon Exercise Of Warrants Outstanding Abstract  
Exercise Price | $ / shares $ 1.25
Number Outstanding at September 30, 2022 1,239,647
Weighted Average Remaining Contractual Life (Years) 4 years 6 months 21 days
Number Exercisable at September 30, 2022 1,239,647